Does APREPITANT Cause Interstitial lung disease? 79 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 79 reports of Interstitial lung disease have been filed in association with APREPITANT (CINVANTI). This represents 1.4% of all adverse event reports for APREPITANT.
79
Reports of Interstitial lung disease with APREPITANT
1.4%
of all APREPITANT reports
31
Deaths
36
Hospitalizations
How Dangerous Is Interstitial lung disease From APREPITANT?
Of the 79 reports, 31 (39.2%) resulted in death, 36 (45.6%) required hospitalization, and 14 (17.7%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for APREPITANT. However, 79 reports have been filed with the FAERS database.
What Other Side Effects Does APREPITANT Cause?
Fatigue (955)
Pyrexia (913)
Dyspnoea (909)
Hypersensitivity (881)
Rash (789)
Alopecia (760)
Gastrointestinal disorder (722)
Pruritus (707)
Confusional state (696)
Glossodynia (696)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which APREPITANT Alternatives Have Lower Interstitial lung disease Risk?
APREPITANT vs APROTININ
APREPITANT vs ARANESP
APREPITANT vs ARAVA
APREPITANT vs AREDIA
APREPITANT vs ARFORMOTEROL